ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,163.67
-0.63%
Dow Jones
38,647.10
-0.17%
Gold vs US Dollar
2,303.855
-0.73%
Brent Oil
81.975
-0.39%
Bitcoin
66,898.83
-1.98%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Guardant Health Inc (GH)

  7. Guardant Health Inc (GH) News

Guardant Health (GH)

Guardant Health Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GH
DateTimeSourceHeadlineSymbolCompany
05/06/202421:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
04/06/202421:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GHGuardant Health Inc
04/06/202413:05Business WireGuardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancerNASDAQ:GHGuardant Health Inc
03/06/202423:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
03/06/202423:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
03/06/202423:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
03/06/202414:18Business WireGuardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trialsNASDAQ:GHGuardant Health Inc
31/05/202421:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GHGuardant Health Inc
31/05/202413:05Business WireGuardant Health Named to TIME100 Most Influential CompaniesNASDAQ:GHGuardant Health Inc
30/05/202413:05Business WireGuardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer ScreeningNASDAQ:GHGuardant Health Inc
24/05/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GHGuardant Health Inc
24/05/202400:03Business WireFDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening OptionNASDAQ:GHGuardant Health Inc
23/05/202412:05Business WireGuardant Health Stock Trading Temporarily Halted; FDA Panel to Assess Premarket Approval Application for Shield Blood Test for Colorectal Cancer ScreeningNASDAQ:GHGuardant Health Inc
22/05/202421:05Business WireGuardant Health to Participate in Upcoming Investor ConferencesNASDAQ:GHGuardant Health Inc
21/05/202413:44Business WireGuardant Health erhält EU-IVDR-Zertifizierung für Flüssigbiopsie Guardant360® CDx zur Erstellung von Tumormutationsprofilen für alle soliden Krebsarten und therapiebegleitende Diagnostika-IndikationenNASDAQ:GHGuardant Health Inc
21/05/202413:44Business WireGuardant Health reçoit la certification IVDR de l’UE pour la biopsie liquide Guardant360® CDx destinée au profilage des mutations tumorales dans tous les cancers solides et les indications de diagnostic compagnonNASDAQ:GHGuardant Health Inc
21/05/202413:05Business WireGuardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic IndicationsNASDAQ:GHGuardant Health Inc
17/05/202413:05Business WireGuardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GHGuardant Health Inc
16/05/202423:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
16/05/202423:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
16/05/202413:05Business WireGuardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease WeekNASDAQ:GHGuardant Health Inc
09/05/202421:59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GHGuardant Health Inc
09/05/202421:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GHGuardant Health Inc
09/05/202421:05Business WireGuardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue GuidanceNASDAQ:GHGuardant Health Inc
07/05/202421:05Business WireGuardant Health to Participate in Upcoming Investor ConferencesNASDAQ:GHGuardant Health Inc
07/05/202413:00Business WireGuardant Health Surpasses 500 Peer-Reviewed Publications MilestoneNASDAQ:GHGuardant Health Inc
06/05/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
06/05/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
06/05/202422:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
22/04/202413:52Business WireFDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23NASDAQ:GHGuardant Health Inc
 Showing the most relevant articles for your search:NASDAQ:GH

Your Recent History

ZBCM
SUSHIUSDT
SushiToken
ASX
BMY
Brumby Resources
COIN
GPKEUR
LSE
77MF
Barclays 25
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved